Perinatal Iron Deficiency: Implications for Mothers and Infants

Neonatology

Volumn 115, Issue 3, 2019, Pages 269-274

  Juul, Sandra E ^a   Derman, Richard J ^b   Auerbach, Michael ^c,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Iron deficiency; Iron insufficiency; Parenteral iron

Indexed keywords

HEMOGLOBIN; IRON DEXTRAN; IRON;

DIET SUPPLEMENTATION; ERYTHROCYTE VOLUME; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; IRON DEFICIENCY ANEMIA; PERINATAL PERIOD; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; ANEMIA; CHEMISTRY; COMPLICATION; FEMALE; FETUS BLOOD; FETUS DEATH; GESTATIONAL AGE; NEWBORN; PREGNANCY; PREVALENCE;

ANEMIA; ANEMIA, IRON-DEFICIENCY; FEMALE; FETAL BLOOD; FETAL DEATH; GESTATIONAL AGE; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; IRON; PREGNANCY; PREVALENCE;

EID: 85061654752     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000495978     Document Type: Review

References (44)

1. Cantor AG, Bougatsos C, Dana T, Blazina I, McDonagh M. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015 Apr; 162(8): 566-76.
2. Daru J, Zamora J, Fernández-Félix BM, Vogel J, Oladapo OT, Morisaki N, et al. Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: A multilevel analysis. Lancet Glob Health. 2018 May; 6(5):e548-54.
3. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al.; Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: A systematic analysis of population- representative data. Lancet Glob Health. 2013 Jul; 1(1):e16-25.
4. Tran PV, Fretham SJ, Carlson ES, Georgieff MK. Long-term reduction of hippocampal brain-derived neurotrophic factor activity after fetal-neonatal iron deficiency in adult rats. Pediatr Res. 2009 May; 65(5): 493-8.
5. Zamora TG, Guiang SF 3rd, Widness JA, Georgieff MK. Iron is prioritized to red blood cells over the brain in phlebotomized anemic newborn lambs. Pediatr Res. 2016 Jun; 79(6): 922-8.
6. Tran PV, Kennedy BC, Lien YC, Simmons RA, Georgieff MK. Fetal iron deficiency induces chromatin remodeling at the Bdnf locus in adult rat hippocampus. Am J Physiol Regul Integr Comp Physiol. 2015 Feb; 308(4):R276-82.
7. Shao J, Lou J, Rao R, Georgieff MK, Kaciroti N, Felt BT, et al. Maternal serum ferritin concentration is positively associated with newborn iron stores in women with low ferritin status in late pregnancy. J Nutr. 2012 Nov; 142(11): 2004-9.
8. Congdon EL, Westerlund A, Algarin CR, Peirano PD, Gregas M, Lozoff B, et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr. 2012 Jun; 160(6): 1027-33.
9. Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status: A longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med. 2006 Nov; 160(11): 1108-13.
10. Lozoff B. Iron deficiency and child development. Food Nutr Bull. 2007 Dec; 28(4 Suppl):S560-71.
11. Drukker L, Hants Y, Farkash R, Ruchlemer R, Samueloff A, Grisaru-Granovsky S. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion. 2015 Dec; 55(12): 2799-806.
12. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR 1998; 47(RR-3): 1-29.
13. Zimmermann MB, Burgi H, Hurrell RF. Iron deficiency predicts poor maternal thyroid status during pregnancy. J Clin Endocrinol Metab. 2007 Sep; 92(9): 3436-40.
14. Auerbach M, James SE, Nicoletti M, Lenowitz S, London N, Bahrain HF, et al. Results of the First American Prospective Study of Intravenous Iron in Oral Iron-Intolerant Iron-Deficient Gravidas. Am J Med. 2017 Dec; 130(12): 1402-7.
15. Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: Iron, cobalamin, and folate. Blood. 2017 Feb; 129(8): 940-9.
16. Scholl TO. Maternal iron status: Relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev. 2011 Nov; 69 Suppl 1:S23-9.
17. Johnson S, Lang A, Sturm M, O'Brien SH. Iron Deficiency without Anemia: A Common Yet Under-Recognized Diagnosis in Young Women with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2016 Dec; 29(6): 628-31.
18. Lorenz L, Peter A, Poets CF, Franz AR. A review of cord blood concentrations of iron status parameters to define reference ranges for preterm infants. Neonatology. 2013; 104(3): 194-202.
19. Cusick SE, Georgieff MK, Rao R. Approaches for Reducing the Risk of Early-Life Iron Deficiency- Induced Brain Dysfunction in Children. Nutrients. 2018 Feb; 10(2): 10.
20. German K, Vu PT, Grelli KN, Denton C, Lee G, Juul SE. Zinc Protoporphyrin-to-Heme Ratio and Ferritin as Measures of Iron Sufficiency in the Neonatal Intensive Care Unit. J Pediatr. 2018 Mar; 194: 47-53.
21. Siddappa AM, Rao R, Long JD, Widness JA, Georgieff MK. The assessment of newborn iron stores at birth: A review of the literature and standards for ferritin concentrations. Neonatology. 2007; 92(2): 73-82.
22. Lorenz L, Arand J, Büchner K, Wacker-Gussmann A, Peter A, Poets CF, et al. Reticulocyte haemoglobin content as a marker of iron deficiency. Arch Dis Child Fetal Neonatal Ed. 2015 May; 100(3):F198-202.
23. WHO: Iron deficiency anaemia: Assessment, prevention and control. WHO/NHD/01.3. Geneva: WHO; 2001.
24. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015 Oct; 126(17): 1981-9.
25. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: Two open-label, randomised controlled trials. Lancet Haematol. 2017 Nov; 4(11):e524-33.
26. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 95: Anemia in pregnancy. Obstet Gynecol. 2008 Jul; 112(1): 201-7.
27. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C; British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012 Mar; 156(5): 588-600.
28. Jahn MR, Andreasen HB, Fütterer S, Nawroth T, Schünemann V, Kolb U, et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm. 2011 Aug; 78(3): 480-91.
29. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: Systematic review and meta-analysis. Mayo Clin Proc. 2015 Jan; 90(1): 12-23.
30. Sav T, Tokgoz B, Sipahioglu MH, Deveci M, Sari I, Oymak O, et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail. 2007; 29(4): 423-6.
31. Myers B, Myers O, Moore J. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med. 2012 Sep; 5(3): 105-7.
32. Hetzel D, Strauss W, Bernard K, Li Z, Urboniene A, Allen LF. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Am J Hematol. 2014 Jun; 89(6): 646-50.
33. Okam MM, Mandell E, Hevelone N, Wentz R, Ross A, Abel GA. Comparative rates of adverse events with different formulations of intravenous iron. Am J Hematol. 2012 Nov; 87(11):E123-4.
34. Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol. 2001 Apr; 60(4): 386-92.
35. Varde KN. Treatment of 300 cases of iron deficiency of pregnancy by total dose infusion of iron-dextran complex. J Obstet Gynaecol Br Commonw. 1964 Dec; 71(6): 919-22.
36. Wong L, Smith S, Gilstrop M, Derman R, Auerbach S, London N, et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 2016 Jun; 91(6): 590-3.
37. Munoz M, Pena-Rosas JP, Robinson S, Milman N, Holzgreve W, Breymann C, et al. Patient blood management in obstetrics: Management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 2018 Feb; 28(1): 22-39.
38. MacQueen BC, Christensen RD, Ward DM, Bennett ST, O'Brien EA, Sheffield MJ, et al. The iron status at birth of neonates with risk factors for developing iron deficiency: A pilot study. J Perinatol. 2017 Apr; 37(4): 436-40.
39. INFeD (iron dextran) US prescribing information (revision September 2009). Available at: Https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abacb7fa-2fc2-471e- 9200-944eeac8ca2a.
40. Ferrlecit (sodium ferric gluconate complex in sucrose) US prescribing information (revision August 2011). Available at: Https://dailymed. nlm.nih.gov/dailymed/drugInfo. cfm?setid=1fe028ff-42ac-4329-b1a5-a9dadfcb79f6.
41. Venofer (iron sucrose) US prescribing information (revision September 2012). Available at: Https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1ab1a22-2b99-4d27- 8b5a-9c3bcd5e3040.
42. Feraheme (ferumoxytol) US prescribing information (revision June 2011). Available at: Https://dailymed.nlm.nih.gov/dailymed/drugInfo. cfm?setid=32b0e320-a739-11dc-a704- 0002a5d5c51b.
43. Monofer (iron [III] isomaltoside 1000) United Kingdom summary of product characteristics (revision June 1, 2012). Available at: Https://www.medicines.org.uk/emc/product/5676.
44. Ferinject (ferric carboxymaltose) United Kingdom summary of product characteristics (revision October 2011). Available at: Https://www.medicines.org.uk/emc/product/5910 .